Improved metabolic control by depletion of Liver X Receptors in mice

Biochemical and Biophysical Research Communications

Volumn 348, Issue 1, 2006, Pages 176-182

  Schuster, Gertrud U ^a,b   Johansson, Lisen ^a   Kietz, Silke ^a,c   Stulnig, Thomas M ^a,d   Parini, Paolo ^a,e   Gustafsson, Jan Åke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Insulin receptor substrate 2; Liver X Receptor; Serum glucose levels

Indexed keywords

C PEPTIDE; CARBOHYDRATE; FATTY ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; LIVER X RECEPTOR; MESSENGER RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; INSULIN BLOOD LEVEL; INSULIN SYNTHESIS; LIPOGENESIS; LIVER LEVEL; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIET; DNA-BINDING PROTEINS; GENE DELETION; INSULIN; LIPID METABOLISM; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

RODENTIA;

EID: 33746843565     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.044     Document Type: Article

References (38)

1. Steffensen K.R., and Gustafsson J.Å. Putative metabolic effects of the liver X receptor (LXR). Diabetes 53 Suppl. 1 (2004) S36-S42
2. Alberti S., Schuster G., Parini P., Feltkamp D., Diczfalusy U., Rudling M., Angelin B., Bjorkhem I., Pettersson S., and Gustafsson J.Å. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J. Clin. Invest. 107 (2001) 565-573
3. Alberti S., Steffensen K.R., and Gustafsson J.Å. Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene 243 (2000) 93-103
4. Steffensen K.R., Nilsson M., Schuster G.U., Stulnig T.M., Dahlman-Wright K., and Gustafsson J.Å. Gene expression profiling in adipose tissue indicates different transcriptional mechanisms of liver X receptors alpha and beta, respectively. Biochem. Biophys. Res. Commun. 310 (2003) 589-593
5. Schuster G.U., Parini P., Wang L., Alberti S., Steffensen K.R., Hansson G.K., Angelin B., and Gustafsson J.Å. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 106 (2002) 1147-1153
6. Francis G.A., Annicotte J.S., and Auwerx J. Liver X receptors: Xcreting Xol to combat atherosclerosis. Trends Mol. Med. 8 (2002) 455-458
7. Millatt L.J., Bocher V., Fruchart J.C., and Staels B. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochim. Biophys. Acta 1631 (2003) 107-118
8. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., Daige C.L., Thomas D., Heyman R.A., Mangelsdorf D.J., Wang X., Lusis A.J., Tontonoz P., and Schulman I.G. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc. Natl. Acad. Sci. USA 99 (2002) 11896-11901
9. Terasaka N., Hiroshima A., Koieyama T., Ubukata N., Morikawa Y., Nakai D., and Inaba T. T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice. FEBS Lett. 536 (2003) 6-11
10. Stulnig T.M., Oppermann U., Steffensen K.R., Schuster G.U., and Gustafsson J.Å. Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51 (2002) 2426-2433
11. Laffitte B.A., Chao L.C., Li J., Walczak R., Hummasti S., Joseph S.B., Castrillo A., Wilpitz D.C., Mangelsdorf D.J., Collins J.L., Saez E., and Tontonoz P. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc. Natl. Acad. Sci. USA 100 (2003) 5419-5424
12. Cao G., Liang Y., Broderick C.L., Oldham B.A., Beyer T.P., Schmidt R.J., Zhang Y., Stayrook K.R., Suen C., Otto K.A., Miller A.R., Dai J., Foxworthy P., Gao H., Ryan T.P., Jiang X.C., Burris T.P., Eacho P.I., and Etgen G.J. Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J. Biol. Chem. 278 (2003) 1131-1136
13. Grefhorst A., van Dijk T.H., Hammer A., van der Sluijs F.H., Havinga R., Havekes L.M., Romijn J.A., Groot P.H., Reijngoud D.J., and Kuipers F. Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E829-E838
14. Dalen K.T., Ulven S.M., Bamberg K., Gustafsson J.Å., and Nebb H.I. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J. Biol. Chem. 278 (2003) 48283-48291
15. Efanov A.M., Sewing S., Bokvist K., and Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 53 Suppl. 3 (2004) S75-S78
16. Folch J., Lees M., and Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957) 497-509
17. Yang J., Goldstein J.L., Hammer R.E., Moon Y.A., Brown M.S., and Horton J.D. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc. Natl. Acad. Sci. USA 98 (2001) 13607-13612
18. Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., and Brown M.S. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J. Biol. Chem. 277 (2002) 9520-9528
19. Schultz J.R., Tu H., Luk A., Repa J.J., Medina J.C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D.J., Lustig K.D., and Shan B. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
20. Chisholm J.W., Hong J., Mills S.A., and Lawn R.M. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res. 44 (2003) 2039-2048
21. Stein D.T., Stevenson B.E., Chester M.W., Basit M., Daniels M.B., Turley S.D., and McGarry J.D. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J. Clin. Invest. 100 (1997) 398-403
22. Randle P.J., Priestman D.A., Mistry S.C., and Halsall A. Glucose fatty acid interactions and the regulation of glucose disposal. J. Cell. Biochem. 55 Suppl. (1994) 1-11
23. Randle P.J. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab. Rev. 14 (1998) 263-283
24. McGarry J.D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258 (1992) 766-770
25. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., and Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
26. Tobin K.A., Ulven S.M., Schuster G.U., Steineger H.H., Andresen S.M., Gustafsson J.Å., and Nebb H.I. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J. Biol. Chem. 277 (2002) 10691-10697
27. Foufelle F., and Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem. J. 366 (2002) 377-391
28. Osborne T.F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 275 (2000) 32379-32382
29. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., Shan B., Brown M.S., Goldstein J.L., and Mangelsdorf D.J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000) 2819-2830
30. Matsuzaka T., Shimano H., Yahagi N., Amemiya-Kudo M., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Tomita S., Sekiya M., Hasty A., Nakagawa Y., Sone H., Toyoshima H., Ishibashi S., Osuga J., and Yamada N. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes 53 (2004) 560-569
31. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
32. White M.F. Insulin signaling in health and disease. Science 302 (2003) 1710-1711
33. Kido Y., Burks D.J., Withers D., Bruning J.C., Kahn C.R., White M.F., and Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest. 105 (2000) 199-205
34. Le Fur S., Le Stunff C., and Bougneres P. Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. Diabetes 51 Suppl. 3 (2002) S304-S307
35. Previs S.F., Withers D.J., Ren J.M., White M.F., and Shulman G.I. Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275 (2000) 38990-38994
36. Shimomura I., Matsuda M., Hammer R.E., Bashmakov Y., Brown M.S., and Goldstein J.L. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6 (2000) 77-86
37. Shirakami A., Toyonaga T., Tsuruzoe K., Shirotani T., Matsumoto K., Yoshizato K., Kawashima J., Hirashima Y., Miyamura N., Kahn C.R., and Araki E. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J. Endocrinol. 174 (2002) 309-319
38. Withers D.J., Burks D.J., Towery H.H., Altamuro S.L., Flint C.L., and White M.F. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23 (1999) 32-40